Brought to you by

Paradigm Genetics raises $43.5mm in IPO
17 Jul 2000
Executive Summary
Paradigm Genetics (functional genomics in nutrition and agricultural) netted $43.5mm in its initial public offering of 6.75mm common shares (including the overallotment) priced at $7 each.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement